MTVA MetaVia Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

MetaVia (MTVA) Stock: Buy, Sell, or Hold?

$1.01
-0.06 (-5.61%) ▼
5d: -22.31% 30d: -27.34% 90d: -33.99%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$1.13 – $1.41
Position: OVERSOLD
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$17.67
+1649.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.00 / $1.78
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: MTVA is down 22.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When MTVA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: MTVA is currently trading at $1.01, which is considered oversold relative to its 30-day fair value range of $1.13 to $1.41.

Technical Outlook: Technically, MTVA is in a downtrend. The price is currently testing key support at $1.00. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $17.67 (+1649.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.13 - $1.41
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

Trading Range & Key Levels

30-Day Trading Range $1.13 - $1.41
Current vs Trading Range OVERSOLD
Support Level $1.00
Resistance Level $1.78
Current Trend Downtrend
Technical data as of Nov 20, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-5.6%)
  • BULLISH: Trading 1649.2% below Wall St target ($17.67)
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.48
Wall Street Target $17.67 (+1649.2%)
Share MTVA Analysis

Share this live MTVA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (MTVA)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Nov 16, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits user expresses anticipation for potential volume in $MTVA due to their belief in the company's love for GLP-1 tickers.
Key Retail Themes: Bullish sentiment towards $MTVA Anticipation for potential volume
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 7:03 AM ET
Data refreshes hourly during market hours. Next update: 8:03 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MTVA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
REGN
Regeneron Pharmaceutical…
BUY
28 analysts
$985 45 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
22 analysts
$298 46 HOLD
PRAX
Praxis Precision Medicin…
STRONG BUY
19 analysts
$674 39 SELL
NAMS
NewAmsterdam Pharma Comp…
STRONG BUY
16 analysts
$50 47 HOLD
DYN
Dyne Therapeutics Inc
STRONG BUY
17 analysts
$34 45 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals